Syndrome of hypothyroidism as a factor of cardiovascular pathology development (literature review)
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 7
Abstract
The article presents pathogenetic data on the development of cardiovascular pathology in reduced thyroid function. Нypothyroidism is associated with an increased risk of coronary heart disease, myocardial infarction, chronic heart failure and cardiovascular mortality, regardless of gender, age and previous cardiovascular disease. This leads to the search for additional influence on the pathogenetic mechanisms of hypothyroidism in order to effectively treat these threatening manifestations and consequences of the disease.
Authors and Affiliations
O. Yu. Horodynska
Dietary changes in patients with diabetes mellitus in combination with gout
To the report experience of author is driven in relation to the dietary changes in patients with diabetes mellitus (DM) and gout. At combination of gout with type 2 DM a ration consists of limitation of meat and increase...
Pathogenic mechanisms of erectile dysfunction development in men with type 1 and type 2 diabetes mellitus
Background. Sexual disorders are one of the most common complications of diabetes mellitus (DM). Often, men with diabetes mellitus have erectile dysfunction (ED). The purpose of the study was to investigate the influence...
Impact of Physical Activity on Dyslipidemia Onset in Children and Adolescents with Type 1 Diabetes Mellitus
The problem of treatment optimization for type 1 diabetes mellitus (DM) in children is not completely resolved so far, while recommendations concerning physical activity (PA) regimen usually do not consider the features...
The Neuro Imaging Description of Giant Pituitary Adenomas Depending on Mechanical Factor
The research aim is to analyze of magnetically-resonance tomography data depending on the mechanical factor of giant pituitary adenomas. Materials and methods. Twenty-two adult patients with giant pituitary adenomas were...
The place of the third generation sulfonylurea glimepiride in modern therapy of type 2 diabetes mellitus
The article considers the pharmacological and clinical aspects of the use of glimepiride, a third generation sulfonylurea, in modern therapy of type 2 diabetes mellitus. The drug is characterized by proven efficacy and s...